Enhancing TRIC-A activity could strengthen mitochondrial resilience in conditions characterized by Ca2+ mishandling and oxidative stress, such as ischemia–reperfusion injury and chronic pressure-overload cardiomyopathy. This evidence concerns the gene TMEM38A and ischemia.